<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38240591</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Enterovirus D68 3C protease antagonizes type I interferon signaling by cleaving signal transducer and activator of transcription 1.</ArticleTitle><Pagination><StartPage>e0199423</StartPage><MedlinePgn>e0199423</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01994-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.01994-23</ELocationID><Abstract><AbstractText>Following the successful control of poliovirus, the re-emergence of respiratory enterovirus D68 (EV-D68), a prominent non-polio enterovirus, has become a serious public health concern worldwide. Host innate immune responses are the primary defense against EV-D68 invasion; however, the mechanism underlying viral evasion of the antiviral activity of interferons (IFN) remains unclear. In this study, we found that EV-D68 inhibited type I IFN signaling by cleaving signal transducer and activator of transcription 1 (STAT1), a crucial factor in cellular responses to interferons and other cytokines. We observed that the prototype and circulating EV-D68 strains conserved their ability to induce STAT1 cleavage and attenuate IFN signal transduction. Further investigation revealed that EV-D68 3C protease cleaves STAT1 at the 131Q residue. Interestingly, not all enterovirus-encoded 3C proteases exhibited this ability. EV-D68 and poliovirus 3C proteases efficiently induced STAT1 cleavage; whereas, 3C proteases from EV-A71, coxsackievirus A16, and echoviruses did not. STAT1 cleavage also abolished the nuclear translocation capacity of STAT1 in response to IFN stimulation to activate downstream signaling elements. Overall, these results suggest that STAT1, targeted by viral protease 3C, is utilized by EV-D68 to subvert the host's innate immune response.IMPORTANCEEnterovirus D68 (EV-D68) has significantly transformed over the past decade, evolving from a rare pathogen to a potential pandemic pathogen. The interferon (IFN) signaling pathway is an important defense mechanism and therapeutic target for the host to resist viral invasion. Previous studies have reported that the EV-D68 virus blocks or weakens immune recognition and IFN production in host cells through diverse strategies; however, the mechanisms of EV-D68 resistance to IFN signaling have not been fully elucidated. Our study revealed that EV-D68 relies on its own encoded protease, 3C, to directly cleave signal transducer and activator of transcription 1 (STAT1), a pivotal transduction component in the IFN signaling pathway, disrupting the IFN-mediated antiviral response. Previous studies on human enteroviruses have not documented direct cleavage of the STAT1 protein to evade cellular immune defenses. However, not all enteroviral 3C proteins can cleave STAT1. These findings highlight the diverse evolutionary strategies different human enteroviruses employ to evade host immunity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaohan</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0002-9947-2077</Identifier><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Haoran</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0008-9261-9033</Identifier><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jiaxin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xize</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Huili</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Wanying</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lili</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4456-840X</Identifier><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Translational Medicine, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>32222005, 82372226</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>82172246</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050794">STAT1 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="Y">3C Viral Proteases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057131" MajorTopicYN="N">Immune Evasion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="Y">Interferon Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050794" MajorTopicYN="N">STAT1 Transcription Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3C</Keyword><Keyword MajorTopicYN="N">EV-D68</Keyword><Keyword MajorTopicYN="N">IFN signaling</Keyword><Keyword MajorTopicYN="N">STAT1</Keyword><Keyword MajorTopicYN="N">immune evasion</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>21</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>9</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38240591</ArticleId><ArticleId IdType="pmc">PMC10878094</ArticleId><ArticleId IdType="doi">10.1128/jvi.01994-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schuster JE, Miller JO, Selvarangan R, Weddle G, Thompson MT, Hassan F, Rogers SL, Oberste MS, Nix WA, Jackson MA. 2015. Severe enterovirus 68 respiratory illness in children requiring intensive care management. J Clin Virol 70:77–82. doi:10.1016/j.jcv.2015.07.298</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.07.298</ArticleId><ArticleId IdType="pubmed">26305825</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Schreiner TL, Maloney JA, Wallace A, Ludke J, Oberste MS, Nix WA, Robinson CC, Glodé MP, Abzug MJ, Dominguez SR. 2015. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet 385:1662–1671. doi:10.1016/S0140-6736(14)62457-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)62457-0</ArticleId><ArticleId IdType="pubmed">25638662</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Haren K, Ayscue P, Waubant E, Clayton A, Sheriff H, Yagi S, Glenn-Finer R, Padilla T, Strober JB, Aldrovandi G, Wadford DA, Chiu CY, Xia D, Harriman K, Watt JP, Glaser CA. 2015. Acute flaccid myelitis of unknown etiology in California, 2012-2015. JAMA 314:2663–2671. doi:10.1001/jama.2015.17275</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.17275</ArticleId><ArticleId IdType="pubmed">26720027</ArticleId></ArticleIdList></Reference><Reference><Citation>Schieble JH, Fox VL, Lennette EH. 1967. A probable new human picornavirus associated with respiratory diseases. Am J Epidemiol 85:297–310. doi:10.1093/oxfordjournals.aje.a120693</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a120693</ArticleId><ArticleId IdType="pubmed">4960233</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudy MJ, Coughlan C, Hixon AM, Clarke P, Tyler KL. 2022. Density analysis of enterovirus D68 shows viral particles can associate with exosomes. Microbiol Spectr 10:e0245221. doi:10.1128/spectrum.02452-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02452-21</ArticleId><ArticleId IdType="pmc">PMC8849102</ArticleId><ArticleId IdType="pubmed">35170992</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W, Wang G, Zhuge J, Nolan SM, Dimitrova N, Fallon JT. 2015. Whole-genome sequence analysis reveals the enterovirus D68 isolates during the United States 2014 outbreak mainly belong to a novel clade. Sci Rep 5:15223. doi:10.1038/srep15223</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15223</ArticleId><ArticleId IdType="pmc">PMC4606740</ArticleId><ArticleId IdType="pubmed">26469882</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Maher K, Schnurr D, Flemister MR, Lovchik JC, Peters H, Sessions W, Kirk C, Chatterjee N, Fuller S, Hanauer JM, Pallansch MA. 2004. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J Gen Virol 85:2577–2584. doi:10.1099/vir.0.79925-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79925-0</ArticleId><ArticleId IdType="pubmed">15302951</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Staring J, Jae LT, Liu Y, Guo H, Slager JJ, de Bruin JW, van Vliet ALW, Blomen VA, Overduin P, Sheng J, de Haan CAM, de Vries E, Meijer A, Rossmann MG, Brummelkamp TR, van Kuppeveld FJM. 2016. Enterovirus D68 receptor requirements unveiled by haploid genetics. Proc Natl Acad Sci USA 113:1399–1404. doi:10.1073/pnas.1524498113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1524498113</ArticleId><ArticleId IdType="pmc">PMC4747778</ArticleId><ArticleId IdType="pubmed">26787879</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sheng J, Baggen J, Meng G, Xiao C, Thibaut HJ, van Kuppeveld FJM, Rossmann MG. 2015. Sialic acid-dependent cell entry of human enterovirus D68. Nat Commun 6:8865. doi:10.1038/ncomms9865</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9865</ArticleId><ArticleId IdType="pmc">PMC4660200</ArticleId><ArticleId IdType="pubmed">26563423</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Liu Y, Lyoo H, van Vliet ALW, Wahedi M, de Bruin JW, Roberts RW, Overduin P, Meijer A, Rossmann MG, Thibaut HJ, van Kuppeveld FJM. 2019. Bypassing pan-enterovirus host factor PLA2G16. Nat Commun 10:3171. doi:10.1038/s41467-019-11256-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11256-z</ArticleId><ArticleId IdType="pmc">PMC6639302</ArticleId><ArticleId IdType="pubmed">31320648</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Guo H, Chang J, Yu Y, Liu G, Zhang N, Willard SH, Zheng S, Yu XF. 2016. ICAM-5/telencephalin is a functional entry receptor for enterovirus D68. Cell Host Microbe 20:631–641. doi:10.1016/j.chom.2016.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.09.013</ArticleId><ArticleId IdType="pubmed">27923705</ArticleId></ArticleIdList></Reference><Reference><Citation>Beutler B. 2004. Innate immunity: an overview. Mol Immunol 40:845–859. doi:10.1016/j.molimm.2003.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2003.10.005</ArticleId><ArticleId IdType="pubmed">14698223</ArticleId></ArticleIdList></Reference><Reference><Citation>Medzhitov R, Janeway C. 2000. Innate immunity. N Engl J Med 343:338–344. doi:10.1056/NEJM200008033430506</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200008033430506</ArticleId><ArticleId IdType="pubmed">10922424</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohto U. 2022. Activation and regulation mechanisms of NOD-like receptors based on structural biology. Front Immunol 13:953530. doi:10.3389/fimmu.2022.953530</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.953530</ArticleId><ArticleId IdType="pmc">PMC9520476</ArticleId><ArticleId IdType="pubmed">36189327</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140:805–820. doi:10.1016/j.cell.2010.01.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.022</ArticleId><ArticleId IdType="pubmed">20303872</ArticleId></ArticleIdList></Reference><Reference><Citation>Palm NW, Medzhitov R. 2009. Pattern recognition receptors and control of adaptive immunity. Immunol Rev 227:221–233. doi:10.1111/j.1600-065X.2008.00731.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2008.00731.x</ArticleId><ArticleId IdType="pubmed">19120487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zong Z, Zhang Z, Wu L, Zhang L, Zhou F. 2021. The functional deubiquitinating enzymes in control of innate antiviral immunity. Adv Sci (Weinh) 8:2002484. doi:10.1002/advs.202002484</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.202002484</ArticleId><ArticleId IdType="pmc">PMC7816709</ArticleId><ArticleId IdType="pubmed">33511009</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Neill LAJ, Bowie AG. 2007. The family of five: TIR-domain-containing adaptors in toll-like receptor signalling. Nat Rev Immunol 7:353–364. doi:10.1038/nri2079</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2079</ArticleId><ArticleId IdType="pubmed">17457343</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, Yanai H, Takaoka A, Taniguchi T. 2005. Regulation of the type I IFN induction: a current view. Int Immunol 17:1367–1378. doi:10.1093/intimm/dxh318</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxh318</ArticleId><ArticleId IdType="pubmed">16214811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivashkiv LB, Donlin LT. 2014. Regulation of type I interferon responses. Nat Rev Immunol 14:36–49. doi:10.1038/nri3581</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3581</ArticleId><ArticleId IdType="pmc">PMC4084561</ArticleId><ArticleId IdType="pubmed">24362405</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips RL, Wang Y, Cheon H, Kanno Y, Gadina M, Sartorelli V, Horvath CM, Darnell JE, Stark GR, O’Shea JJ. 2022. The JAK-STAT pathway at 30: much learned, much more to do. Cell 185:3857–3876. doi:10.1016/j.cell.2022.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.09.023</ArticleId><ArticleId IdType="pmc">PMC9815833</ArticleId><ArticleId IdType="pubmed">36240739</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser LJ, Langereis MA, Rabouw HH, Wahedi M, Muntjewerff EM, de Groot RJ, van Kuppeveld FJM. 2019. Essential role of enterovirus 2A protease in counteracting stress granule formation and the induction of type I interferon. J Virol 93:e00222-19. doi:10.1128/JVI.00222-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00222-19</ArticleId><ArticleId IdType="pmc">PMC6498061</ArticleId><ArticleId IdType="pubmed">30867299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J, Pang Z, Zhou Z, Li X, Liu S, Cheng J, Liu P, Tan W, Wang Z, Wang T. 2021. Enterovirus D68 protease 2A(pro) targets TRAF3 to subvert host innate immune responses. J Virol 95:e01856-20. doi:10.1128/JVI.01856-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01856-20</ArticleId><ArticleId IdType="pmc">PMC7925118</ArticleId><ArticleId IdType="pubmed">33148796</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Liu L, Lei X, Zhou Z, He B, Wang J. 2016. 3C protease of enterovirus D68 inhibits cellular defense mediated by interferon regulatory factor 7. J Virol 90:1613–1621. doi:10.1128/JVI.02395-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02395-15</ArticleId><ArticleId IdType="pmc">PMC4719596</ArticleId><ArticleId IdType="pubmed">26608321</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Li L, Lei X, Zhou H, Zhou Z, He B, Wang J. 2014. Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by toll-like receptor 3. J Virol 88:6650–6659. doi:10.1128/JVI.03138-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03138-13</ArticleId><ArticleId IdType="pmc">PMC4054379</ArticleId><ArticleId IdType="pubmed">24672048</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui Y, Su J, Wang H, Chang J, Wang S, Zheng W, Cai Y, Wei W, Gordy JT, Markham R, Kong W, Zhang W, Yu X-F, Pfeiffer JK. 2017. Disruption of MDA5-mediated innate immune responses by the 3C proteins of coxsackievirus A16, coxsackievirus A6, and enterovirus D68. J Virol 91:e00546-17. doi:10.1128/JVI.00546-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00546-17</ArticleId><ArticleId IdType="pmc">PMC5469270</ArticleId><ArticleId IdType="pubmed">28424289</ArticleId></ArticleIdList></Reference><Reference><Citation>Chau DHW, Yuan J, Zhang H, Cheung P, Lim T, Liu Z, Sall A, Yang D. 2007. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis 12:513–524. doi:10.1007/s10495-006-0013-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-006-0013-0</ArticleId><ArticleId IdType="pubmed">17195095</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstaub D, Gradi A, Bercovitch Z, Grosmann Z, Nophar Y, Luria S, Sonenberg N, Kahana C. 2000. Poliovirus 2A protease induces apoptotic cell death. Mol Cell Biol 20:1271–1277. doi:10.1128/MCB.20.4.1271-1277.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.4.1271-1277.2000</ArticleId><ArticleId IdType="pmc">PMC85262</ArticleId><ArticleId IdType="pubmed">10648613</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Yang J, Li H, Zhang Z, Ji Z, Zhao L, Wei W. 2023. Enterovirus D68 infection induces TDP-43 cleavage, aggregation, and neurotoxicity. J Virol 97:e0042523. doi:10.1128/jvi.00425-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00425-23</ArticleId><ArticleId IdType="pmc">PMC10134869</ArticleId><ArticleId IdType="pubmed">37039659</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley CM, Watson JT, Nix WA, Curns AT, Rogers SL, Brown BA, Conover C, Dominguez SR, Feikin DR, Gray S, et al. . 2015. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation. Lancet Respir Med 3:879–887. doi:10.1016/S2213-2600(15)00335-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(15)00335-5</ArticleId><ArticleId IdType="pmc">PMC5693332</ArticleId><ArticleId IdType="pubmed">26482320</ArticleId></ArticleIdList></Reference><Reference><Citation>Anonymous . 2011. Clusters of acute respiratory illness associated with human enterovirus 68--Asia, Europe, and United States, 2008-2010. MMWR Morb Mortal Wkly Rep 60:1301–1304.</Citation><ArticleIdList><ArticleId IdType="pubmed">21956405</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm-Hansen CC, Midgley SE, Fischer TK. 2016. Global emergence of enterovirus D68: a systematic review. Lancet Infect Dis 16:e64–e75. doi:10.1016/S1473-3099(15)00543-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00543-5</ArticleId><ArticleId IdType="pubmed">26929196</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB, Heise M. 2011. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 7:e1001311. doi:10.1371/journal.ppat.1001311</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001311</ArticleId><ArticleId IdType="pmc">PMC3059221</ArticleId><ArticleId IdType="pubmed">21436888</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews DDT, Vlok M, Akbari Bani D, Hay BN, Mohamud Y, Foster LJ, Luo H, Overall CM, Jan E. 2023. Cleavage of 14-3-3Ε by the enteroviral 3C protease dampens RIG-I-mediated antiviral signaling. J Virol 97:e0060423. doi:10.1128/jvi.00604-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00604-23</ArticleId><ArticleId IdType="pmc">PMC10506458</ArticleId><ArticleId IdType="pubmed">37555661</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Langereis MA, Lork M, Nguyen M, Hato SV, Lanke K, Emdad L, Bhoopathi P, Fisher PB, Lloyd RE, van Kuppeveld FJM. 2014. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol 88:3369–3378. doi:10.1128/JVI.02712-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. 2013. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol 87:1690–1698. doi:10.1128/JVI.01855-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01855-12</ArticleId><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman MC, Wells AI, Ciomperlik-Patton J, Myerburg MM, Yang L, Konopka-Anstadt J, Coyne CB. 2021. Respiratory and intestinal epithelial cells exhibit differential susceptibility and innate immune responses to contemporary EV-D68 isolates. eLife 10:e66687. doi:10.7554/eLife.66687</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.66687</ArticleId><ArticleId IdType="pmc">PMC8285104</ArticleId><ArticleId IdType="pubmed">34196272</ArticleId></ArticleIdList></Reference><Reference><Citation>Strehlow I, Schindler C. 1998. Amino-terminal signal transducer and activator of transcription (STAT) domains regulate nuclear translocation and STAT deactivation. J Biol Chem 273:28049–28056. doi:10.1074/jbc.273.43.28049</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.43.28049</ArticleId><ArticleId IdType="pubmed">9774421</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung HC, Wang HC, Shih SR, Teng IF, Tseng CP, Hsu JA. 2011. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J Infect Dis 203:1784–1790. doi:10.1093/infdis/jir174</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir174</ArticleId><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro A, Anand-Apte B, Tanabe Y, Feldman G, Larner AC. 2003. A PI-3 kinase-dependent, STAT1-independent signaling pathway regulates interferon-stimulated monocyte adhesion. J Leukoc Biol 73:540–545. doi:10.1189/jlb.1002508</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1002508</ArticleId><ArticleId IdType="pubmed">12660229</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramana CV, Grammatikakis N, Chernov M, Nguyen H, Goh KC, Williams BR, Stark GR. 2000. Regulation of C-myc expression by IFN-gamma through STAT1-dependent and -independent pathways. EMBO J 19:263–272. doi:10.1093/emboj/19.2.263</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/19.2.263</ArticleId><ArticleId IdType="pmc">PMC305560</ArticleId><ArticleId IdType="pubmed">10637230</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil MP, Bohn E, O’Guin AK, Ramana CV, Levine B, Stark GR, Virgin HW, Schreiber RD. 2001. Biologic consequences of STAT1-independent IFN signaling. Proc Natl Acad Sci USA 98:6680–6685. doi:10.1073/pnas.111163898</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.111163898</ArticleId><ArticleId IdType="pmc">PMC34412</ArticleId><ArticleId IdType="pubmed">11390995</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard S, Couderc T, Destombes J, Thiesson D, Delpeyroux F, Blondel B. 1999. Poliovirus induces apoptosis in the mouse central nervous system. J Virol 73:6066–6072. doi:10.1128/JVI.73.7.6066-6072.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.7.6066-6072.1999</ArticleId><ArticleId IdType="pmc">PMC112668</ArticleId><ArticleId IdType="pubmed">10364359</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>